Initial ribociclib plus endocrine therapy for HR+/HER2β advanced breast cancer in preβ and postmenopausal Chinese women: Primary results from a phase 2 randomized study
Article in Cancer Medicine (August 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Cancer Medicine (August 2024)
Article in Cancer Cell International (March 2024)
Preprint in Research Square (October 2023)